跳至主要内容
临床试验/NCT03571919
NCT03571919撤回4 期

Efficacy of Intravenous Lidocaine Infusion for Traumatic Rib Fracture Pain Control

Stanford University1 个研究点 分布在 1 个国家开始时间: 2018年6月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
撤回
试验地点
1
主要终点
Opioid pain medicine usage

研究概览

简要总结

Patients with traumatic rib fractures not receiving regional anesthesia through a epidural or nerve block catheter will be recruited for the study. Once enrolled, they will be randomized to receive either intravenous lidocaine or intravenous saline for control of pain related to their rib fractures. In addition, they will receive other pain medications, such as acetaminophen, gabapentin, and opioid pain medications. Our primary outcome is a decrease in their opioid medication requirements.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

盲法说明

Immediate care providers (nurses, primary teams) will be blinded; however, lidocaine levels will be monitored by the acute pain service, a consulting team providing direct care to the patient, who will not be blinded.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged 18 or older with 2+ rib fractures or > 65 with 2+ rib fractures Enrollment within 16 hours of admission Inability to receive epidural placement or other catheter-based regional anesthesia (coagulopathy, anticoagulation, bacteremia or infection over epidural site, patient refusal, vertebral fracture, spinal cord injury, inability to cooperate with procedure, BMI > 40) Isolated rib fracture (no other major injury or anticipation for invasive procedure)

排除标准

  • Inability to participate in traditional pain measures Severe alcohol withdrawal Chronic pain requiring opiates prior to admission GCS < 13 or inability to report pain Medical instability Positive pressure ventilation, either via non-invasive mask or endotracheal tube Hemodynamic instability or shock Flail chest with clinical evidence of paradoxical rib motion Contraindication to lidocaine History of or current bradycardia (HR < 50) or heart block (Mobitz II or 3rd degree) New onset or uncontrolled seizures Allergy to amide-type local anesthetic
  • Enrollment in other study that may affect the results of this study

研究组 & 干预措施

Control

Placebo Comparator

Will receive normal saline bolus and infusion and have sham lab draws every 8 hours.

干预措施: Saline infusion (Drug)

Lidocaine

Active Comparator

Will receive lidocaine bolus and infusion and have lidocaine lab draws every 8 hours.

干预措施: Lidocaine infusion (Drug)

结局指标

主要结局

Opioid pain medicine usage

时间窗: Average per 24 hours

Total opioid pain medicine usage

次要结局

  • Pain score(5 days)
  • PCA requirements(5 days)
  • Length of stay(5 days)
  • Respiratory failure(5 days)
  • Death(up to 30 days)
  • Mobility(2 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验